Unaudited Consolidated Financial reports and Management’s Discussion and Analysis reports for WeedMD Inc. will be posted here quarterly. Please visit SEDAR for a complete listing of corporate filings and archived filings for WeedMD Inc.
Click here to read important news about Proxy documentation and voting.
2021 – Q1 Management’s Discussion and Analysis (MD&A)
2021 – Q1 Interim Condensed Financial Statements
2021 – Q1 Certification of Interim Filings – CEO, George Scorsis
2021 – Q1 Certification of Interim Filings – CFO, Beth Carreon
2021 – Management Information Circular (AGSM)
2021 – Management Cease Trade Order (MCTO), May 3, 2021
2020 – Year End Management’s Discussion and Analysis (MD&A)
2020 – Year End Consolidated Financial Statements
2020 – Certification of Annual Filings Venture Issuer – CEO, George Scorsis
2020 – Certification of Annual Filings Venture Issuer – CFO, Beth Carreon
2020 – Q3 Management’s Discussion and Analysis (MD&A)
2020 – Q3 Amended and Restated Interim Condensed Financial Statements
2020 – Q2 Management’s Discussion and Analysis (MD&A)
2020 – Q2 Interim Condensed Financial Statements
2020 – Q1 Management’s Discussion and Analysis (MD&A)
2020 – Q1 Interim Condensed Financial Statements
2020 – Management Information Circular (AGSM)
2020 – Form of Proxy
2020 – Certificate re dissemination to Shareholders
2020 – Notice of Meeting
2020 – Management Information Circular (Special Meeting)
2019 – Year End Management’s Discussion and Analysis (MD&A)
2019 – Year End Consolidated Financial Statements
2019 – Q3 Management’s Discussion and Analysis (MD&A)
2019 – Q3 Interim Condensed Financial Statements
2019 – Q2 Management’s Discussion and Analysis (MD&A)
2019 – Q2 Interim Condensed Financial Statements
2019 – Q1 Management’s Discussion and Analysis (MD&A)
2019 – Q1 Interim Condensed Financial Statements
2019 – Certification of Interim Filings – Keith Merker
2019 – Certification of Interim Filings – Nichola Thompson
2019 – Notice of Meeting and Management Information Circular
2019 – Notice and Access
2019 – Form of Proxy
2019 – Voting Instruction Form
2018 – Year End Management’s Discussion and Analysis (MD&A)
2018 – Year End Consolidated Financial Statements
2018 – Q3 Management’s Discussion and Analysis (MD&A)
2018 – Q3 Interim Condensed Financial Statements
2018 – Q2 Management’s Discussion and Analysis (MD&A)
2018 – Q2 Interim Condensed Financial Statements
2018 – Q1 Management’s Discussion and Analysis (MD&A)
2018 – Q1 Interim Condensed Financial Statements
2017- Year End Management’s Discussion and Analysis (MD&A)
2017- Year End Consolidated Financial Statements
2017- Q3 Management’s Discussion and Analysis (MD&A)
2017- Q3 Interim Condensed Financial Statements
2017- Q2 Management’s Discussion and Analysis (MD&A)
2017- Q2 Interim Condensed Financial Statements
